Embracing Generative AI in Clinical Research and Beyond: Opportunities, Challenges and Solutions
Leading experts recently explored how generative AI could revolutionize clinical research through automated documentation and enhanced trial efficiency. Their findings, published in JACC: Advances, outline crucial steps for successful AI integration while addressing technical, ethical, and regulatory challenges to ensure more inclusive and equitable research outcomes.
Accelerating Evidence Generation: Addressing Critical Challenges and Charting a Path Forward
Healthcare leaders have united to tackle the mounting challenges of expensive and inefficient drug development in an era of rising healthcare costs and aging populations. Their recommendations, published in the Journal of Clinical and Translational Science, chart a path toward more equitable, efficient, and inclusive clinical trials that better serve diverse communities.
Drug Development for Major Chronic Health Conditions–Aligning With Growing Public Health Needs
Read insights from a recent DCRI Think Tanks where experts discussed the current state of drug development for chronic health conditions, identified key barriers, and formulated six action items to accelerate drug development.
Lessons from COVID-19 for Pandemic Preparedness: Proceedings From a Multistakeholder Think Tank
A recent publication in the journal Clinical Infectious Diseases highlights key takeaways from a DCRI Think Tank centered on the insights gained from the COVID-19 pandemic and 10 key steps on how this acquired knowledge can help inform the next pandemic response.
"Click and Mortar" Opportunities for Digitization and Consumerism in Trials
Explore how the integration of digital tools and consumer-oriented approaches in clinical trials can enhance participant diversity and recruitment efficiency while addressing challenges in equity, ethics, and security.